Department of Breast and Sarcoma Surgery, National Institute of Oncology, Budapest, Hungary.
Department of Surgery, University of Debrecen, Debrecen, Hungary.
Pathol Oncol Res. 2022 Jun 15;28:1610377. doi: 10.3389/pore.2022.1610377. eCollection 2022.
This text is based on the recommendations accepted by the 4th Hungarian Consensus Conference on Breast Cancer, modified on the basis of the international consultation and conference within the frames of the Central-Eastern European Academy of Oncology. The recommendations cover non-operative, intraoperative and postoperative diagnostics, determination of prognostic and predictive markers and the content of cytology and histology reports. Furthermore, they address some specific issues such as the current status of multigene molecular markers, the role of pathologists in clinical trials and prerequisites for their involvement, and some remarks about the future.
本文本基于第 4 届匈牙利乳腺癌共识会议接受的建议,在中东欧肿瘤学学院框架内的国际咨询和会议基础上进行了修改。这些建议涵盖了非手术、手术中和手术后的诊断、预后和预测标志物的确定,以及细胞学和组织学报告的内容。此外,它们还涉及一些具体问题,如多基因分子标志物的现状、病理学家在临床试验中的作用及其参与的前提条件,以及对未来的一些看法。